Life sciences is seeing strong growth given the huge supply and demand imbalance in the sector. On the demand side, we’ve seen phenomenal growth in life sciences companies globally during the past decade. That growth has been driven by a number of factors, but one of them has been a significant increase in venture capital [VC], which has been deployed into university spin-out companies to help accelerate their growth and discovery of new treatments.
Continue reading this article?
Register for free and get access to Investment Officer International:
- Exclusive for professional investors
- Cancel anytime
- Unlimited access: web, app and newsletters
Registration takes less than 1 minute.
No payment details required
Register for free and get access to Investment Officer Luxembourg:
- Exclusive for professional investors
- Cancel anytime
- Unlimited access: web, app and newsletters
Registration takes less than 1 minute.
No payment details required
